Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:BEAT News 10 December 2025 - 17 December 2025

HeartBeam (BEAT) Stock News Today: FDA Clearance Ignites Rally, Analysts Lift Targets, and What Investors Are Watching Next (Dec. 17, 2025)

HeartBeam (BEAT) Stock News Today: FDA Clearance Ignites Rally, Analysts Lift Targets, and What Investors Are Watching Next (Dec. 17, 2025)

December 17, 2025 — HeartBeam, Inc. (NASDAQ: BEAT) has moved from “interesting microcap medtech story” to “market’s attention magnet” in a hurry. The spark: FDA 510(k) clearance for HeartBeam’s 12-lead ECG synthesis software for at-home arrhythmia assessment, granted after the company successfully appealed a prior “Not Substantially Equivalent” (NSE) outcome. HeartBeam, Inc. In the days since, BEAT stock has seen sharp swings and outsized volume, a familiar pattern when a small-cap name lands a major regulatory milestone. At the Dec. 16 close, BEAT traded around $3.44, up roughly 31% on the day, and early Dec. 17 pre-market quotes indicated continued
17 December 2025
·
HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views

HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views

As of December 11, 2025, HeartBeam, Inc. (NASDAQ: BEAT) has abruptly moved from obscure micro‑cap to one of the hottest tickers in medtech, after winning a pivotal U.S. FDA clearance for its cable‑free, at‑home 12‑lead ECG synthesis software. The stock closed at $1.55 on December 10, up roughly 92% from the prior close of $0.81, with trading volume exploding to more than 270 million shares, versus an average in the low millions. StockAnalysis+1 Around midday on December 11, BEAT was still trading near that level, giving the company a market capitalization of roughly $53 million. StockAnalysis Below is a breakdown
11 December 2025
··
Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

New York – December 10, 2025 — Wall Street closed higher on Wednesday after the Federal Reserve delivered its third interest‑rate cut of 2025, lifting the Dow, S&P 500 and Nasdaq and setting the stage for a powerful “stock picker’s” session beneath the surface. Reuters+1 While the major indices moved less than 1% each, a cluster of small‑ and mid‑cap names exploded higher by 40–390% during regular trading, with several of them still among the biggest movers in after‑hours trading. According to StockAnalysis, the top 10 U.S. gainers by percentage at the close were dominated by micro‑caps, speculative biotech, and
10 December 2025
········

Stock Market Today

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
GE Vernova stock closes up nearly 6% — what to watch before Monday’s trade

GE Vernova stock closes up nearly 6% — what to watch before Monday’s trade

7 February 2026
GE Vernova shares jumped 5.6% to $779.35 Friday as Wall Street rallied and the company reported 1.1 GW of U.S. wind repower orders for 2025. The company also closed its $5.3 billion purchase of the remaining Prolec GE stake and completed a $2.6 billion senior notes offering. Investors await next week’s U.S. jobs and inflation data.
Citi stock jumps 6% as consent-order exit talk builds — what to watch next week

Citi stock jumps 6% as consent-order exit talk builds — what to watch next week

7 February 2026
Citigroup shares rose 6% to $122.69 at Friday’s close after a Reuters report said executives are more optimistic about completing key consent orders this year. Citi also announced a $2.3 billion preferred stock redemption and a matching program for employee “Trump Accounts.” Investors await next week’s U.S. economic data and Citi conference appearances.
Go toTop